|
biomedicina slovenica |
"GOSERELIN" : 7
-
De Laurentiis Michelino; Borštnar Simona
Full population results from the core phase of CompLEEment-1, a phase 3b study of ribociclib plus letrozole as first-line therapy for advanced breast cancer in an expanded population
2021 ►
-
Jelen-Jurič Jožica; Umičević Snežana; Vrhovnik Kristina; Zakotnik Branko
Subkutana aplikacija goserelina (Zoladex) - implantanta s podaljšanim sproščanjem
2006 ►
-
Hodolič Marina; Maffione Anna Margherita; Fettich Jurij; Gubina Borut; Cimitan Marino; Rubello Domenico
Metastatic Prostate Cancer Proven by 18F-FCH PET/CT Staging Scan in Patient With Normal PSA but High PSA Doubling Time
2012 ►
-
Jagodič Klemen; Bizjak Igor; Erklavec Marko; Poteko Sandi; Korošec Helena; Kmetec Andrej; Tršinar Bojan
Quality of life in patients with prostate cancer treated with LH-RH agonists
2008 ►
-
Goldhirsch A; Lindtner J; Eržen D; Majdič E; Štabuc B; Plesničar A; Golouh R; Lamovec J; Jančar J; Vrhovec I; Kramberger M
Adjuvant chemotherapy followed by goserelin versus either modality alone for premenopausal lymph node-negative breast cancer: a randomized trial
2003 ►
-
Vlaisavljević Veljko; Reljić Milan; Gavrić-Lovrec Vida; Kovačič Borut
Comparable effectiveness using flexible single-dose GnRH antagonist (centrorelix) and single-dose long GnRH agonist (goserelin) protocol for IVF cycles - a prospective, randomized study
2003 ►
-
Castiglione-Gertch M; O'Neill A; Gelber RD; Nasi ML; Rabaglio M; Lindtner J; Crivellari D; Forbes J; Fey M; Perey L
Is the addition of adjuvant chemotherapy always necessary in node negative (N-) pre/perimenopausal breast cancer patients (pts) who recive goserelin?
2002 ►
Nova poizvedba
Pripombe
Na vrh strani
Inštitut za biostatistiko in medicinsko informatiko